Cancer BiologybioRxivPreprint
ALDH1 subtype-specific inhibitor targets key cancerous epithelial cell populations in aggressive subtypes of breast cancer
Raquel Pequerul, A. Constantinescu, Bassam Janji…·Mileidys Perez-Alea
This study identifies ALDH1A3 as a therapeutic target in aggressive breast cancers and develops ABD0171, a selective inhibitor showing antitumor and antimetastatic effects.
3 citations